Search Results

Deals

Heska Corporation Completes Acquisition of LightDeck Diagnostics

Heska Corporation announced the completion of acquisition of 100% of the shares of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics, a pioneer in planar waveguide fluorescence immunoassay diagnostics with strong manufacturing capabilities and research and development expertise.

January 3, 2023

·

3 min read

Deals

Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development Efforts

Heska Corporation announced that the Company has entered a definitive agreement to acquire 100% of the share capital of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics, a pioneer in innovative planar waveguide fluorescence immunoassay diagnostics with strong manufacturing and specialized production capabilities.

September 12, 2022

·

6 min read

Policy

Radical Imaging Announces FDA Clearance for FlexView Diagnostic, its SaaS Image Viewer for Diagnostic Use.

Radical Imaging, a trailblazer in medical imaging viewer solutions, proudly announces that FlexView Diagnostic, its SaaS web DICOM viewer product, received FDA clearance for diagnostic use.

June 24, 2024

·

2 min read

Pharm Country

Quest Diagnostics Releases 2023 Corporate Responsibility Report

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

June 27, 2024

·

3 min read

Deals

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

Quest Diagnostics, a leader in diagnostic information services, announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.

June 11, 2024

·

3 min read

Business

Mosaic Diagnostics Appoints Healthcare Industry Veteran Rob Rebak as CEO

Mosaic Diagnostics is pleased to announce the appointment of Rob Rebak as Chief Executive Officer.

June 27, 2024

·

3 min read

Business

Progentec Diagnostics Announces Appointment of Immunology Expert Dr. Bernard Rubin

Progentec Diagnostics, a leader in diagnostic and digital technologies for management of autoimmune diseases, announced that Bernard R. Rubin, DO, MPH, seasoned rheumatology and immunology expert, has joined Progentec’s leadership team as Chief Medical Officer.

June 17, 2024

·

2 min read

BioCapital

Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics

Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective as of July 1, 2024.

June 19, 2024

·

6 min read

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.

June 18, 2024

·

1 min read

Business

Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens.

June 19, 2024

·

1 min read